Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Selective escalation of imatinib therapy and early switching to nilotinib in de novo chronic phase CML patients: interim results from the TIDELL-II trial(legacy) | 116 |
| Selective escalation of imatinib therapy and early switching to nilotinib in de novo chronic phase CML patients: interim results from the TIDELL-II trial(legacy) | 86 |
Total Visits per Month
| December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
|---|---|---|---|---|---|---|---|
| Selective escalation of imatinib therapy and early switching to nilotinib in de novo chronic phase CML patients: interim results from the TIDELL-II trial | 1 | 4 | 1 | 4 | 2 | 11 | 1 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| Germany | 29 |
| United States | 29 |
| China | 24 |
| France | 14 |
| Australia | 9 |
| Netherlands | 8 |
| Vietnam | 8 |
| Hong Kong SAR China | 6 |
| Argentina | 3 |
| Ireland | 1 |
Top City Views
| Views | |
|---|---|
| Hanoi | 8 |
| Rotterdam | 8 |
| Kaleen | 7 |
| Nanjing | 6 |
| New York | 4 |
| Beijing | 3 |
| Nürnberg | 3 |
| Ashburn | 2 |
| Eagle Mountain | 2 |
| Boardman | 1 |